Company: BLTE
Filing Date: 2025-12-02
Form Type: 424B5
Source: 0001104659-25-117702
Chunk: 72

Company: BELITE BIO, INC
Filing Date: 2025-12-02
Form: 424B5
Chunk 72
---
2025 and for the nine months ended September 30, 2024 and 2025 attached as Exhibit 99.2;

•

the description of our ordinary shares contained in our registration statement on Form 8-A, filed with the SEC on April 20, 2022, and any amendment or report filed with the SEC for the purpose of updating the description; and

•

the information specifically incorporated by reference herein from our reports of foreign private issuer on Form 6-K filed with the SEC on February 6, 2025, February 27, 2025, March 17, 2025( two filings), March 18, 2025, March 28, 2025, April 15, 2025, May 14, 2025, May 21, 2025, July 2, 2025, August 7, 2025, August 11, 2025, September 8, 2025, November 10, 2025and December 1, 2025 (two filings).

In addition, any reports on Form 6-K submitted to the SEC prior to the termination of the offering that we specifically identify in such forms as being incorporated by reference into the registration statement of which this prospectus supplement forms a part.

Certain statements in and portions of this prospectus supplement update and replace information in the above-listed documents incorporated by reference. Likewise, statements in or portions of a future document incorporated by reference in this prospectus supplement may update and replace statements in and portions of this prospectus supplement or the above-listed documents. In the case of a conflict or inconsistency between information contained in this prospectus supplement and information incorporated by reference into this prospectus supplement, you should rely on the information contained in the document that was filed later.

Copies of all documents incorporated by reference in this prospectus supplement, other than exhibits to those documents unless such exhibits are specially incorporated by reference in this prospectus supplement, will be provided at no cost to each person, including any beneficial owner, who receives a copy of this prospectus supplement on the written or oral request of that person made to:

Belite Bio, Inc

12750 High Bluff Drive Suite 475, 
 San Diego, CA 92130 
 Tel: + 1-858-246-6240 
 Attention: Chief Financial Officer

<div align='center'>S-50</div>

TABLE OF CONTENTS

### PROSPECTUS

#### Belite Bio,